Three-year outcomes and correlative analyses in patients with non–small cell lung cancer (NSCLC) and a very high PD-L1 tumor proportion score (TPS) ≥ 90% treated with first-line pembrolizumab Meeting Abstract
| Authors: | Ricciuti, B.; Elkrief, A.; Alessi, J. V. M.; Wang, X.; de Castro Barrichello, A. P.; Pecci, F.; Lamberti, G.; Lindsay, J.; Sharma, B.; Felt, K.; Nishino, M.; Sholl, L. M.; Rodig, S. J.; Schoenfeld, A. J.; Awad, M. M. |
| Abstract Title: | Three-year outcomes and correlative analyses in patients with non–small cell lung cancer (NSCLC) and a very high PD-L1 tumor proportion score (TPS) ≥ 90% treated with first-line pembrolizumab |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680302230 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.9043 |
| Notes: | Meeting Abstract: 9043 -- Meeting also held virtually -- Source: Wos |
